We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$4.6B
AUM Growth
+$92.4M
Cap. Flow
+$24.6M
Cap. Flow %
0.54%
Top 10 Hldgs %
18.8%
Holding
642
New
126
Increased
236
Reduced
155
Closed
101

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$40.7M
2
OGE icon
OGE Energy
OGE
+$26.9M
3
HBAN icon
Huntington Bancshares
HBAN
+$25.6M
4
CMS icon
CMS Energy
CMS
+$15.8M
5
XOM icon
ExxonMobil
XOM
+$15.8M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$41.3M
2
EXC icon
Exelon
EXC
+$39.7M
3
DAL icon
Delta Air Lines
DAL
+$38.3M
4
TWX
Time Warner Inc
TWX
+$16.1M
5
GS icon
Goldman Sachs
GS
+$9.08M

Sector Composition

Rank Sector Weight
1 Financials 19.2%
2 Technology 14.33%
3 Healthcare 13.61%
4 Consumer Discretionary 8.88%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERF
526
DELISTED
Enerplus Corporation
ERF
$126K ﹤0.01%
10,000
TTOO
527
DELISTED
T2 Biosystems, Inc
TTOO
$124K ﹤0.01%
+3
New +$114K
AROC icon
528
Archrock
AROC
$5.8B
$121K ﹤0.01%
10,076
SNR
529
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$107K ﹤0.01%
14,157
-7,105
-33% -$56.5K
BVH
530
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$106K ﹤0.01%
+2,346
New +$108K
BB icon
531
BlackBerry
BB
$5.26B
$104K ﹤0.01%
+10,753
New +$120K
MCRB icon
532
Seres Therapeutics
MCRB
$48.4M
$93K ﹤0.01%
543
WIN
533
DELISTED
Windstream Holdings Inc
WIN
$91K ﹤0.01%
17,187
+12,177
+243% +$85.4K
CTG
534
DELISTED
Computer Task Group, Inc.
CTG
$88K ﹤0.01%
+11,340
New +$86.2K
INFI
535
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$83K ﹤0.01%
+43,690
New +$88.3K
OMED
536
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$50K ﹤0.01%
21,597
ASXC
537
DELISTED
Asensus Surgical, Inc.
ASXC
$44K ﹤0.01%
769
XXII
538
22nd Century Group
XXII
$1.48M
0
FLNA
539
Filana Therapeutics
FLNA
$48.1M
$23K ﹤0.01%
+11,373
New +$97.5K
ADXS
540
DELISTED
Advaxis Inc
ADXS
$18K ﹤0.01%
821
OTIV
541
DELISTED
OTI On Track Innovations Ltd
OTIV
$12K ﹤0.01%
10,000
AAP icon
542
Advance Auto Parts
AAP
$3.49B
-11,462
Closed -$1.36M
ALG icon
543
Alamo Group
ALG
$2.05B
-10,094
Closed -$1.11M
AMT icon
544
American Tower
AMT
$80.4B
-26,161
Closed -$3.8M
AMWD
545
DELISTED
American Woodmark
AMWD
-17,906
Closed -$1.76M
ANET icon
546
Arista Networks
ANET
$238B
-72,192
Closed -$1.15M
AP icon
547
Ampco-Pittsburgh
AP
$193M
-10,231
Closed -$91K
ASMB icon
548
Assembly Biosciences
ASMB
$529M
-2,977
Closed -$1.75M
ASRT
549
DELISTED
Assertio
ASRT
-231
Closed -$91K
BGC icon
550
BGC Group
BGC
$4.89B
-261,568
Closed -$2.26M

Similar funds

Zacks Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Zacks Investment Management held 642 positions worth $4.6B, up 2.1% from $4.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Zacks Investment Management's Q2 2018 filing shows 126 new, 236 increased, 155 reduced and 101 closed positions. Its largest new stake was Medtronic: 487,323 shares worth $41.7M. The largest sale was Marathon Petroleum, an estimated $41.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Zacks Investment Management's largest Q2 2018 buy was Medtronic: 487,323 shares worth $41.7M.
  • Zacks Investment Management added most to ExxonMobil in Q2 2018, an estimated $15.8M increase.
  • Zacks Investment Management's biggest Q2 2018 reduction was Marathon Petroleum, cutting an estimated $41.3M.
  • Zacks Investment Management fully exited Exelon in Q2 2018, selling an estimated $39.7M.
  • Zacks Investment Management's ten largest holdings make up 19% of its $4.6B portfolio in Q2 2018.
  • Zacks Investment Management opened 126 new positions and closed 101 in Q2 2018.
  • Zacks Investment Management's portfolio value rose 2.1% quarter-over-quarter to $4.6B.

Based on Zacks Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.